Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline plus trimethoprim-sulfamethoxazole versus doxycycline plus rifampicin for brucellosis
PACTR202210778524094Recruiting
- Sponsor
- Assiut University Hospitals
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of doxycycline, trimethoprim + sulfamethoxazole and rifampicin in brucellosis (2 arms), sponsored by Assiut University Hospitals. Started Sep 2022; status: recruiting.
02
Drugs
doxycyclinetrimethoprim + sulfamethoxazolerifampicin
03
Conditions
brucellosis
Beyond the preview
Go deeper on PACTR202210778524094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202210778524094.